Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 6.18 is in line with its 5-year average of 5.96, around the middle of its 5-year range (4.08–8.87).
As of the fiscal period ended Tuesday, June 30, 2026. 1.36% above its 12-month average of 6.09.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 6.18.
QUICK RATIO (ACID-TEST)
6.18
QUICK RATIO (ACID-TEST) AVG TTM
6.09
QUICK RATIO (ACID-TEST) AVG 3Y
6.13
QUICK RATIO (ACID-TEST) AVG 5Y
5.96
QUICK RATIO (ACID-TEST) AVG 10Y
6.66
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+1.36%
CURRENT VS 3Y AVG
+0.75%
CURRENT VS 5Y AVG
+3.52%
CURRENT VS 10Y AVG
-7.24%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.19
median of 727 covered companies
CURRENT VS SECTOR MEDIAN
+93.58%
vs the sector median at left
Fulgent Genetics, Inc.
Market Cap
$593.86M
Quick Ratio (Acid-Test)
6.18
TTM Avg
6.09
3Y Avg
6.13
5Y Avg
5.96
Market Cap
$587.06M
Quick Ratio (Acid-Test)
2.17
TTM Avg
3.09
3Y Avg
3.48
5Y Avg
3.24
Market Cap
$600.84M
Quick Ratio (Acid-Test)
6.06
TTM Avg
2.91
3Y Avg
9.30
5Y Avg
9.54
Market Cap
$610.22M
Quick Ratio (Acid-Test)
1.49
TTM Avg
1.44
3Y Avg
1.41
5Y Avg
1.41
Market Cap
$574.01M
Quick Ratio (Acid-Test)
6.74
TTM Avg
3.69
3Y Avg
2.52
5Y Avg
2.35
Market Cap
$569.16M
Quick Ratio (Acid-Test)
9.36
TTM Avg
2.17
3Y Avg
1.76
5Y Avg
2.63
Market Cap
$566.81M
Quick Ratio (Acid-Test)
2.36
TTM Avg
2.55
3Y Avg
5.33
5Y Avg
7.55
Market Cap
$625.84M
Quick Ratio (Acid-Test)
3.05
TTM Avg
5.21
3Y Avg
6.01
5Y Avg
5.25
Market Cap
$560.00M
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fulgent Genetics, Inc. (FLGT) | $593.86M | 6.18 | 6.09 | 6.13 | 5.96 |
| OrthoPediatrics Corp. (KIDS)vs › | $587.06M | 2.17 | 3.09 | 3.48 | 3.24 |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $600.84M | 6.06 | 2.91 | 9.30 | 9.54 |
| AngioDynamics, Inc. (ANGO)vs › | $610.22M | 1.49 | 1.44 | 1.41 | 1.41 |
| Aquestive Therapeutics, Inc. (AQST)vs › | $574.01M | 6.74 | 3.69 | 2.52 | 2.35 |
| CytomX Therapeutics, Inc. (CTMX)vs › | $569.16M | 9.36 | 2.17 | 1.76 | 2.63 |
| CorMedix Inc. (CRMD)vs › | $566.81M | 2.36 | 2.55 | 5.33 | 7.55 |
| Prime Medicine, Inc. (PRME)vs › | $625.84M | 3.05 | 5.21 | 6.01 | 5.25 |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $556.32M | 5.42 | 12.18 | 12.18 | 12.18 |
Quick Ratio
6.18
Excludes inventory
Current Ratio
6.34
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 6.18 |
| 2026-03-31 | 5.18 |
| 2025-12-31 | 6.35 |
| 2025-09-30 | 6.87 |
| 2025-06-30 | 5.88 |
| 2025-03-31 | 6.19 |
| 2024-12-31 | 4.74 |
| 2024-09-30 | 4.30 |
| 2024-06-30 | 5.18 |
| 2024-03-31 | 5.00 |
| 2023-12-31 | 6.88 |
| 2023-09-30 | 8.87 |
| 2023-06-30 | 8.06 |
| 2023-03-31 | 7.03 |
| 2022-12-31 | 7.08 |
| 2022-09-30 | 6.72 |
| 2022-06-30 | 5.20 |
| 2022-03-31 | 5.33 |
| 2021-12-31 | 5.70 |
| 2021-09-30 | 4.08 |
| 2021-06-30 | 4.45 |
| 2021-03-31 | 3.22 |
| 2020-12-31 | 3.90 |
| 2020-09-30 | 3.39 |
| 2020-06-30 | 6.00 |
| 2020-03-31 | 6.11 |
| 2019-12-31 | 9.89 |
| 2019-09-30 | 7.35 |
| 2019-06-30 | 8.28 |
| 2019-03-31 | 7.48 |
| 2018-12-31 | 15.69 |
| 2018-09-30 | 18.81 |
| 2018-06-30 | 14.30 |
| 2018-03-31 | 17.95 |
| 2017-12-31 | 15.43 |
| 2017-09-30 | 13.90 |
| 2017-06-30 | 16.28 |
| 2017-03-31 | 9.96 |
| 2016-12-31 | 14.18 |
| 2016-09-30 | 2.23 |
| 2016-06-30 | 4.23 |
| 2016-03-31 | 3.88 |
| 2015-12-31 | 3.96 |
| 2015-09-30 | 0.00 |
| 2015-06-30 | 0.00 |
| 2015-03-31 | 0.00 |
